GUIDED THERAPEUTICS, INC. (GTHP) Gross margin 2017–2025
GUIDED THERAPEUTICS, INC. (GTHP) gross margin by fiscal year — reported gross profit divided by reported revenue.
74.4%FY2025 · since FY2017: -117.2% → 74.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 74.4% | +45.9 pp |
| FY2024 | 28.6% | -8.2 pp |
| FY2023 | 36.7% | +559.8 pp |
| FY2022 | -523.1% | -547.8 pp |
| FY2021 | 24.7% | -115.5 pp |
| FY2020 | 140.2% | +234.6 pp |
| FY2019 | -94.4% | -38.3 pp |
| FY2018 | -56.1% | +61.1 pp |
| FY2017 | -117.2% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More GTHP financial trends
GTHP RevenueGTHP Net incomeGTHP Net marginGTHP Gross profitGTHP Operating incomeGTHP Operating marginGTHP Operating cash flowGTHP Free cash flowGTHP Capital expendituresGTHP Return on equityGTHP Stock buybacksGTHP Dividends paidGTHP Total assetsGTHP Total liabilitiesGTHP Shareholders’ equityGTHP overview →